retatrutide type 2 diabetes phase 2 results a1c In the 3 TRANSCEND-T2D-1 trial, patients with experienced:, โ Up to 2% reduction, โ 90% achieved an A1C <7%, โ 85% achieved an A1C <6.5%, โ 46% achieved normal glycemia ๐ฉบ Retatrutide in type 2
Pay in 4 interest-free payments of $5.58 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours ยท Estimated delivery Nov 8 - Nov 13

























